Dr. Rigaut received a B.A. in Biology from Virginia Wesleyan College in 1982, an M.S. in Microbiology from N.Y. Medical College in 1985 and a Ph.D. in Microbiology and Molecular Genetics from Rutgers University in 1992. Dr. Rigaut was admitted to practice before the USPTO in 1998 and received a J.D. degree from Rutgers University in Camden in 1999. Kate was admitted to practice law in NJ and PA in 2000 and joined the firm as a partner in 2018. She currently serves as a faculty member for the Practicing Law Institute Patent Law Boot Camp held annually in New York City and volunteers as an IP expert for the annual QED Proof of Concept program at the Science Center in Philadelphia.

​Kate has extensive laboratory experience in the fields of virology, immunology, and molecular biology. As a Staff Fellow at the National Institutes of Health, Kate was involved in the development of novel immunotoxins targeting the T Cell Receptor.

Kate Rigaut has also contributed a book chapter to Research administration and Management Elliott C. Kulakowski, Lynne U. Chronister eds, Research Enterprise entitled “Applying for the United States Patent Protection” Kate has also written a chapter on non-disclosure agreements which also appeared in Research Administration and Management.

Kate has extensive experience in patent prosecution, including preparation and filing of patent applications, amendments, and responses to PTO Official Actions on a variety of subjects including cancer genes, transgenic plants, RNA viruses, monoclonal antibodies, antisense technologies, and compositions involved in anti-inflammatory responses. She also prepared patentability and freedom to operate opinions. Kate also has experience in drafting, reviewing, and amending license, option, and MTA agreements.